Safety and efficiency evidence, for a collaborative pharmaceutical service program, as is currently implemented in Swiss nursing homes.
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Presentation
- By: ANGUISH, Isabelle (University of Lausanne, Lausanne, Switzerland)
- Co-author(s): Locca (University of Lausanne, Lausanne, Switzerland)
Burgy (Pharmacists’ association of the canton of Fribourg, Fribourg, Switzerland)
Repond (4Pharmacists’ association of the canton of Fribourg, Fribourg, Switzerland)
Michielan (Association fribourgeoise des institutions pour personnes âgées (AFIPA-VFA), Fribourg, Switzerland)
Bugnon (University of Lausanne, Lausanne, Switzerland)
Ageing of the population is a worldwide trend. By 2050, the Swiss statistical forecast indicates that the population aged 65 and over will double, and that of 80 and over will triple. At the current time more than 20% of seniors (80 years of age and over) live in long-term care facilities. Such residents suffer from functional decline, and a high.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.